Health and Fitness Health and Fitness

Wed, February 29, 2012

[ Wed, Feb 29th 2012 ] - Market Wire

AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.;; BUY

[ Wed, Feb 29th 2012 ] - Market Wire

Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference

[ Wed, Feb 29th 2012 ] - Market Wire

Thera Max Cold and Flu Brand Receives Great Benef .. Ongoing Social Media Marketing Awareness Program

[ Wed, Feb 29th 2012 ] - Market Wire

Celsion to Present at Upcoming Investor Conferences in March 2012

[ Wed, Feb 29th 2012 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Levetiracetam Oral Solution

[ Wed, Feb 29th 2012 ] - Market Wire

BioSpecifics Technologies Corp. Announces Present .. ons at Two Upcoming Investor Conferences in March

[ Wed, Feb 29th 2012 ] - Market Wire

Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Wed, Feb 29th 2012 ] - Market Wire

Avanir Pharmaceuticals and Concert Pharmaceutical .. to Develop and Commercialize Deuterium-modified D

[ Wed, Feb 29th 2012 ] - Market Wire

AMRI Expands Quality Control Leadership to Support Future Growth

[ Wed, Feb 29th 2012 ] - Market Wire

SET Corp Receives $875,000 Private Investment for Bakken Shale Saltwater Disposal

[ Wed, Feb 29th 2012 ] - Market Wire

Marina Biotech Presents Advances in Oral Delivery .. of Nucleic Acids at AsiaTIDES Conference in Tokyo

[ Wed, Feb 29th 2012 ] - Market Wire

Mylan Launches First Equivalent Product to Lexapro Tablets

[ Wed, Feb 29th 2012 ] - Market Wire

Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2012 Results

[ Wed, Feb 29th 2012 ] - Market Wire

Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer

[ Wed, Feb 29th 2012 ] - Market Wire

Horizon Pharma Announces $50.8 Million Private Placement

[ Wed, Feb 29th 2012 ] - Market Wire

Arrowhead Announces Patent Issuance Covering siRNA Inhibitors of HIF-2a (EPAS1)

[ Wed, Feb 29th 2012 ] - Market Wire

BioLineRx Announces Receipt of Notice of Allowanc .. ing BCM (BL-1040), a Novel Medical Device for Pre

[ Wed, Feb 29th 2012 ] - Market Wire

Biogen Idec levert aanvraag in bij FDA voor goedk .. ale BG-12 voor behandeling van Multiple Sclerosis

[ Wed, Feb 29th 2012 ] - Market Wire

Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference

[ Wed, Feb 29th 2012 ] - Market Wire

ProMetic Finalizes Its Agreement With Celgene Corporation

[ Wed, Feb 29th 2012 ] - Market Wire

OncoSec's OMS ElectroOncology Technology Platform .. n Medical Device amp;; Diagnostic Industry

[ Wed, Feb 29th 2012 ] - Market Wire

Auxilium Partners With the National Organization for Rare Disorders to Observe Rare Disease Day

Tue, February 28, 2012

[ Tue, Feb 28th 2012 ] - Market Wire

Faruqi amp;; Faruqi, LLP Announces Investigation of China Sky One Medical, Inc.

[ Tue, Feb 28th 2012 ] - Market Wire

Quest Diagnostics Declares Quarterly Cash Dividend

[ Tue, Feb 28th 2012 ] - Market Wire

Lucid, Inc. Announces Separation of Unit to Common Stock and Warrant

[ Tue, Feb 28th 2012 ] - Market Wire

Healthways to Present at the Barclays Capital Global Healthcare Conference

[ Tue, Feb 28th 2012 ] - Market Wire

Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference

[ Tue, Feb 28th 2012 ] - Market Wire

Alere to Acquire eScreen, Inc.

[ Tue, Feb 28th 2012 ] - Market Wire

Cigna Corporation Announces Appearance at the Cowen 32nd Annual Health Care Conference

[ Tue, Feb 28th 2012 ] - Market Wire

Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference

[ Tue, Feb 28th 2012 ] - Market Wire

Johnson amp;; Johnson to Participate in Co .. en and Company 32nd Annual Health Care Conference

[ Tue, Feb 28th 2012 ] - Market Wire

Teva to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference

[ Tue, Feb 28th 2012 ] - Market Wire

AdCare Health Systems to Present at the ROTH Capi .. Partners 24th Annual Conference on March 12, 2012

[ Tue, Feb 28th 2012 ] - Market Wire

AVI BioPharma Announces FDA Approval to Proceed W .. Dosing of AVI-6003 for Treatment of Marburg Virus

[ Tue, Feb 28th 2012 ] - Market Wire

ARIAD Reports 2011 Financial Results and Outlines .. Development and Commercialization Plans for 2012

[ Tue, Feb 28th 2012 ] - Market Wire

POZEN Reports Fourth Quarter & Year End 2011 Results

[ Tue, Feb 28th 2012 ] - Market Wire

UnitedHealthcare to Strengthen Service to Florida .. of Preferred Care Partners and Medica Healthcare

[ Tue, Feb 28th 2012 ] - Market Wire

Aviation Security in China Continues to Purchase .. lant Sciences' Explosives Trace Detection Devices

[ Tue, Feb 28th 2012 ] - Market Wire

BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan

[ Tue, Feb 28th 2012 ] - Market Wire

ICON Acquires PriceSpective

[ Tue, Feb 28th 2012 ] - Market Wire

Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12

[ Tue, Feb 28th 2012 ] - Market Wire

OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma

[ Tue, Feb 28th 2012 ] - Market Wire

Astex Pharmaceuticals to Announce 2011 Fourth Qua .. r and Year-End Financial Results on March 5, 2012

[ Tue, Feb 28th 2012 ] - Market Wire

Inovio Pharmaceuticals to Present at Cowen and ROTH Investor Conferences

Mon, February 27, 2012

[ Mon, Feb 27th 2012 ] - Market Wire

Forest Laboratories, Inc. and Gedeon Richter Plc. .. ositive Phase III Trials with the Investigational

[ Mon, Feb 27th 2012 ] - Market Wire

BioLineRx Ltd. Announces Closing of $15 Million Private Placement to Institutional Investors

[ Mon, Feb 27th 2012 ] - Market Wire

Cloudant Names Andy Palmer to Its Board of Directors

[ Mon, Feb 27th 2012 ] - Market Wire

BrainStorm'sNurOwna" Stem Cell Technology Offers Hope for Treating Huntington Disease

[ Mon, Feb 27th 2012 ] - Market Wire

Alexion to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Mon, Feb 27th 2012 ] - Market Wire

CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012

[ Mon, Feb 27th 2012 ] - Market Wire

OPKO Invests in BioZone Pharmaceuticals, Inc.

[ Mon, Feb 27th 2012 ] - Market Wire

Raging Capital Calls Upon Board of Taro Pharmaceu .. ediately Reject Sun Pharma's Acquisition Proposal

[ Mon, Feb 27th 2012 ] - Market Wire

Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide Conference

[ Mon, Feb 27th 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation

[ Mon, Feb 27th 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Akorn, Inc. and Ironwood Pharmaceuticals, Inc.

[ Mon, Feb 27th 2012 ] - Market Wire

Cancer Therapies From Dendreon and AEterna Zentaris Poised to Boost Profits

[ Mon, Feb 27th 2012 ] - Market Wire

Cancer Treatments Evolve - Exelixis and Seattle Genetics Look to Lead

[ Mon, Feb 27th 2012 ] - Market Wire

St. Jude Medical Announces Increase in Quarterly Dividend

[ Mon, Feb 27th 2012 ] - Market Wire

ARIAD to Present at the Cowen and Company 32nd Annual Health Care Conference

[ Mon, Feb 27th 2012 ] - Market Wire

VentriPoint Completes Validation Study for Pulmonary Arterial Hypertension Application

[ Mon, Feb 27th 2012 ] - Market Wire

Brookdale to Present at 2012 RBC Capital Markets' Healthcare Conference on February 29

[ Mon, Feb 27th 2012 ] - Market Wire

Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference

[ Mon, Feb 27th 2012 ] - Market Wire

Delcath Announces First CHEMOSAT Procedures in Germany

[ Mon, Feb 27th 2012 ] - Market Wire

Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012

[ Mon, Feb 27th 2012 ] - Market Wire

PAREXEL International to Present at Cowen Healthc .. Conference and Raymond James Investors Conference

Sat, February 25, 2012

[ Sat, Feb 25th 2012 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against TranS1 Inc.

Fri, February 24, 2012

[ Fri, Feb 24th 2012 ] - Market Wire

Nektar to Announce Financial Results for the Four .. 11 on Wednesday, February 29, 2012, After Close o

[ Fri, Feb 24th 2012 ] - Market Wire

Update on Motion for Authorization to Institute Class Action Against the Company

[ Fri, Feb 24th 2012 ] - Market Wire

Aetna Board of Directors Declares Quarterly Cash Dividend, Authorizes Additional Share Repurchases

[ Fri, Feb 24th 2012 ] - Market Wire

Greatbatch, Inc. to Participate in the 2012 RBC Capital Marketsa Healthcare Conference

[ Fri, Feb 24th 2012 ] - Market Wire

Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference

[ Fri, Feb 24th 2012 ] - Market Wire

Dual Inhibition of MET and VEGF Signaling With Ca .. zantinib Blocks Tumor Invasiveness and Metastasis

[ Fri, Feb 24th 2012 ] - Market Wire

International Drug & Explosives Detection Company .. enta Corp. Announces Orders Since January 1, 2012

[ Fri, Feb 24th 2012 ] - Market Wire

IGSM GROUP INC., Holding Company Completes First Acquisition

[ Fri, Feb 24th 2012 ] - Market Wire

Perception, Opportunity in Volatility - Research .. is on VIVUS, Inc. and Arena Pharmaceuticals, Inc.

[ Fri, Feb 24th 2012 ] - Market Wire

BIOLASE Announces the Introduction of the Waterla .. Lasers at the Chicago Dental Society Midwinter M

[ Fri, Feb 24th 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Becton, .. on and Co. and Health Management Associates, Inc.

[ Fri, Feb 24th 2012 ] - Market Wire

Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing

[ Fri, Feb 24th 2012 ] - Market Wire

NxStage Kicks Off Annual Dialysis Conference 2012 .. brity and Former NxStage User Stephen Furst and O

[ Fri, Feb 24th 2012 ] - Market Wire

Titan Medical Inc. Lists on OTCQX Market in the USA

[ Fri, Feb 24th 2012 ] - Market Wire

BrainStorm Featured on CNBC

[ Fri, Feb 24th 2012 ] - Market Wire

Heska Announces Quarterly Dividend of $0.10 per Share

[ Fri, Feb 24th 2012 ] - Market Wire

HERBORIUM GROUP Announces Signing the Letter of I .. ina Health Resource Inc. for Possible Acquisition

[ Fri, Feb 24th 2012 ] - Market Wire

SANUWAVE Announces Distribution Agreement for Canada

[ Fri, Feb 24th 2012 ] - Market Wire

OncoSec to Present at 10th Annual BioPartnering North America

[ Fri, Feb 24th 2012 ] - Market Wire

Threshold Pharmaceuticals to Present at the Cowen Health Care Conference

[ Fri, Feb 24th 2012 ] - Market Wire

Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler

Thu, February 23, 2012

[ Thu, Feb 23rd 2012 ] - Market Wire

Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences

[ Thu, Feb 23rd 2012 ] - Market Wire

Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

Avid Bioservices to Present at IBC's Antibody Development and Production Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

National Health Scan Inc. (NHSN) Merger Introduction

[ Thu, Feb 23rd 2012 ] - Market Wire

DURECT to Participate in Upcoming Healthcare Conferences

[ Thu, Feb 23rd 2012 ] - Market Wire

Cigna Corporation Announces Appearance at the Citi 2012 Global Health Care Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

Hospira Joins the Generic Pharmaceutical Association

[ Thu, Feb 23rd 2012 ] - Market Wire

Amarantus BioSciences to Present at the 2012 Nati .. ent Banking Association Conference in New Orleans

[ Thu, Feb 23rd 2012 ] - Market Wire

BIOLASE and Cefla Dental Group Announce Exclusive Distribution Agreement

[ Thu, Feb 23rd 2012 ] - Market Wire

SecureAlert, Inc. Reports Record Monitoring Revenues

[ Thu, Feb 23rd 2012 ] - Market Wire

PROLOR Biotech to Present Preclinical Data on Its .. ors VIIa and IX at European Hemophilia Conference

[ Thu, Feb 23rd 2012 ] - Market Wire

Theragenics Reports Revenue & Earnings for Fourth Quarter & Year-End 2011

[ Thu, Feb 23rd 2012 ] - Market Wire

MAP Pharmaceuticals Issued Additional U.S. Patent .. id Treatment of Migraine Based Upon Pharmacokinet

[ Thu, Feb 23rd 2012 ] - Market Wire

Nuvo Research provides an update on its Pennsaid franchise

[ Thu, Feb 23rd 2012 ] - Market Wire

Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy

[ Thu, Feb 23rd 2012 ] - Market Wire

Implant Sciences' Quantum Sniffer Explosives and .. Be Exhibited at Security Trade Show in Madrid, Sp

[ Thu, Feb 23rd 2012 ] - Market Wire

[ Thu, Feb 23rd 2012 ] - Market Wire

PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium

[ Thu, Feb 23rd 2012 ] - Market Wire

Teleflex Introduces the FloCath Quicka" Female Catheter and Insertion Kit

Wed, February 22, 2012

[ Wed, Feb 22nd 2012 ] - Market Wire

INSERTING and REPLACING Human Genome Sciences to .. scuss Fourth-Quarter and Full-Year 2011 Financial

[ Wed, Feb 22nd 2012 ] - Market Wire

Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R)

[ Wed, Feb 22nd 2012 ] - Market Wire

Hospira to Present at the Barclays Capital Global Healthcare Conference

[ Wed, Feb 22nd 2012 ] - Market Wire

Boston Scientific to Participate in 2012 RBC Capital Markets' Global Healthcare Conference

[ Wed, Feb 22nd 2012 ] - Market Wire

Hologic to Launch Four New Products at the European Congress of Radiology in Vienna

[ Wed, Feb 22nd 2012 ] - Market Wire

AT&T Selected as Carrier to Connect Boston Scient .. vices: Offering Physician and Patient Convenience

[ Wed, Feb 22nd 2012 ] - Market Wire

ATamp;;T Selected as Carrier to Connect Bo .. vices: Offering Physician and Patient Convenience

[ Wed, Feb 22nd 2012 ] - Market Wire

Mettler-Toledo International Inc. Announces Webcast of Presentation at Citi Health Care Conference

[ Wed, Feb 22nd 2012 ] - Market Wire

Concentra Selects Allscripts Electronic Health Record for Concentra Medical Centers

[ Wed, Feb 22nd 2012 ] - Market Wire

Critical Outcome Technologies Inc. Selected for Trade Mission to BioPartnering North America

[ Wed, Feb 22nd 2012 ] - Market Wire

AVI BioPharma Regains NASDAQ Compliance

[ Wed, Feb 22nd 2012 ] - Market Wire

Synta Provides Clinical Update and Reports Fourth Quarter and Year End 2011 Financial Results

[ Wed, Feb 22nd 2012 ] - Market Wire

Shire Announces European Approval of Manufacturing Facility for VPRIV (velaglucerase alfa)

[ Wed, Feb 22nd 2012 ] - Market Wire

US Patent Office Rejects All Claims in Second MonoSol Patent

[ Wed, Feb 22nd 2012 ] - Market Wire

SciClone Pharmaceuticals to Present at RBC Capital Markets' Global Healthcare Conference

[ Wed, Feb 22nd 2012 ] - Market Wire

Marina Biotech Receives Notice of Allowance for U .. s Lipid Based Nucleic Acid Drug Delivery Platform

[ Wed, Feb 22nd 2012 ] - Market Wire

PAREXEL to Address Proven Approaches to Realize S .. lue at Partnerships in Clinical Trials Conference

[ Wed, Feb 22nd 2012 ] - Market Wire

The Ensign Group, Inc. Secures $21.5 Million Loan From RBS Asset Finance, Inc.

[ Wed, Feb 22nd 2012 ] - Market Wire

Centene Corporation Awarded Missouri Managed Care Contract

[ Wed, Feb 22nd 2012 ] - Market Wire

Lexicon Pharmaceuticals Provides Clinical Pipelin .. 11 Fourth Quarter and Full Year Financial Results

[ Wed, Feb 22nd 2012 ] - Market Wire

Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation

Tue, February 21, 2012

[ Tue, Feb 21st 2012 ] - Market Wire

Natus Medical to Hold 2011 Fourth Quarter Financial Results Conference Call on February 28

[ Tue, Feb 21st 2012 ] - Market Wire

BRILINTA (ticagrelor) Added to American College o .. tions on Antithrombotic Therapy and Prevention of

[ Tue, Feb 21st 2012 ] - Market Wire

Genomma Lab Internacional Announces Non-binding P .. tige Brands Holdings for $16.60 Per Share in Cash

[ Tue, Feb 21st 2012 ] - Market Wire

Response Genetics Regains NASDAQ Compliance

[ Tue, Feb 21st 2012 ] - Market Wire

Horizon Pharma to Present at the Cowen and Company Health Care Conference

[ Tue, Feb 21st 2012 ] - Market Wire

Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers

[ Tue, Feb 21st 2012 ] - Market Wire

AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences

[ Tue, Feb 21st 2012 ] - Market Wire

Theratechnologies Announces a Supply, Distributio .. ng Agreement With Actelion Pharmaceuticals Canada

[ Tue, Feb 21st 2012 ] - Market Wire

China Cord Blood Corporation to Report Third Quar .. irst Nine Months of Fiscal 2012 Financial Results

[ Tue, Feb 21st 2012 ] - Market Wire

Repligen Announces FDA Grant of Priority Review for SecreFloa" NDA

[ Tue, Feb 21st 2012 ] - Market Wire

Isis Pharmaceuticals to Present at the 2012 Citi Global Health Care Conference

[ Tue, Feb 21st 2012 ] - Market Wire

Oncolytics Biotech Inc. Enters into Sponsorship A .. for Randomized Phase II Study in Prostate Cancer

[ Tue, Feb 21st 2012 ] - Market Wire

Oral Treprostinil New Drug Application Accepted by FDA for Review

[ Tue, Feb 21st 2012 ] - Market Wire

PDL BioPharma to Present at Upcoming Conferences

[ Tue, Feb 21st 2012 ] - Market Wire

Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

[ Tue, Feb 21st 2012 ] - Market Wire

Questcor Recognized by Child Neurology Foundation .. tstanding Corporate Responsibility and Leadership

[ Tue, Feb 21st 2012 ] - Market Wire

Capital Senior Living Corporation to Present at R .. al Healthcare Conference on Wednesday, February 2

[ Tue, Feb 21st 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Positive Phas .. ults of TH-302 in Patients With Pancreatic Cancer

[ Tue, Feb 21st 2012 ] - Market Wire

Simcere Pharmaceutical Group to Announce Fourth Q .. 011 Financial Results on Wednesday, March 7, 2012

[ Tue, Feb 21st 2012 ] - Market Wire

GlucAffect Blood Sugar Management Formula From Reliv Earns Patent

[ Tue, Feb 21st 2012 ] - Market Wire

Inovio's Scientific Advisory Board Chairman Elect .. erican Association for the Advancement of Science

Mon, February 20, 2012

[ Mon, Feb 20th 2012 ] - Market Wire

Sirona Dental Systems Validate and Approve Objet .. l Production to Their Worldwide Resellers and Den

[ Mon, Feb 20th 2012 ] - Market Wire

Galapagos announces GSK decision to exercise opti .. r investigational medicines GLPG0778 and GLPG0555

[ Mon, Feb 20th 2012 ] - Market Wire

Immunotec Provides Corporate Update and Year End Financial Results

[ Mon, Feb 20th 2012 ] - Market Wire

Immunotec Announces Proposed Share Consolidation

[ Mon, Feb 20th 2012 ] - Market Wire

Kristi Ann Matus to Head Aetnaas Government Services Organization

[ Mon, Feb 20th 2012 ] - Market Wire

Cubist Pharmaceuticals to Present at February/March Investor Conferences

[ Mon, Feb 20th 2012 ] - Market Wire

Dako Enters Into an Additional Collaboration With .. ion Diagnostic Test (pharmDx(TM)) for an Investig

[ Mon, Feb 20th 2012 ] - Market Wire

Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference

[ Mon, Feb 20th 2012 ] - Market Wire

Theragenics to Report Fourth Quarter and Year-end 2011 Financial Results Thursday, February 23

[ Mon, Feb 20th 2012 ] - Market Wire

2012 Economic Outlook -- Report Highlights Boston .. ific Corporation and Varian Medical Systems, Inc.

[ Mon, Feb 20th 2012 ] - Market Wire

2012 Economic Outlook -- Report Highlights Hologic, Inc. and Mattel, Inc.

[ Mon, Feb 20th 2012 ] - Market Wire

Anvita Health Integrates Smart Problem List Inside Covisint and AT&T Healthcare Community Online

[ Mon, Feb 20th 2012 ] - Market Wire

Pfizer and GlaxoSmithKline Look to Curb Costs as Generic Competition Cuts Into Revenues

[ Mon, Feb 20th 2012 ] - Market Wire

Pharmaceutical Employees Fearful of Losing Jobs as Patent Cliffs Loom

[ Mon, Feb 20th 2012 ] - Market Wire

WellCare Health Plans Implements MedAssurant's Star Advantagea" Solution

[ Mon, Feb 20th 2012 ] - Market Wire

PAREXEL International to Present at Citi Global Healthcare Conference

Sat, February 18, 2012

[ Sat, Feb 18th 2012 ] - Market Wire

Bull amp;; Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.

[ Sat, Feb 18th 2012 ] - Market Wire

Bull & Lifshitz, LLP Announces Investigation of SeraCare Life Sciences, Inc.

Fri, February 17, 2012

[ Fri, Feb 17th 2012 ] - Market Wire

Corcept Therapeutics Incorporated Announces FDA A .. istone): First and Only Approved Medication for C

[ Fri, Feb 17th 2012 ] - Market Wire

Gilead maakt gegevens bekend voor Genotype 1 Null .. atitis C patinten ingeschreven in ELECTRON-studie

[ Fri, Feb 17th 2012 ] - Market Wire

3 Reasons to Fall in Love with Soy For American Heart Month

[ Fri, Feb 17th 2012 ] - Market Wire

Greatbatch Announces the Acquisition of NeuroNexus

[ Fri, Feb 17th 2012 ] - Market Wire

ProMetic Improves its Short Term Liquidity by $5.0 Million

[ Fri, Feb 17th 2012 ] - Market Wire

TheraSphere proporciona esperanza para los pacientes con cncer de hgado de Turqua

[ Fri, Feb 17th 2012 ] - Market Wire

Gilead verffentlicht Daten fr die an der ELECTRON .. is-C-Patienten mit Genotyp 1, die als Nullrespond

[ Fri, Feb 17th 2012 ] - Market Wire

TheraSphere gibt Leberkrebspatienten in der Trkei Hoffnung

[ Fri, Feb 17th 2012 ] - Market Wire

Abbott Announces 40th Consecutive Annual Increase in Quarterly Dividend

[ Fri, Feb 17th 2012 ] - Market Wire

HCA Announces Collaboration with AirStrip Technologies

[ Fri, Feb 17th 2012 ] - Market Wire

Idera Pharmaceuticals Announces Retirement of Dr. .. Wyngaarden as a Member of the Board of Directors

[ Fri, Feb 17th 2012 ] - Market Wire

A Forward Look, the Year Ahead - Featured Researc .. rmaceuticals, Inc. and ISIS Pharmaceuticals, Inc.

[ Fri, Feb 17th 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights MAKO Surgical Corp. and IAC/InterActiveCorp

[ Fri, Feb 17th 2012 ] - Market Wire

Universal Health Services, Inc. to Participate In Two Upcoming Healthcare Conferences

[ Fri, Feb 17th 2012 ] - Market Wire

Sunrise to Host Conference Call and Webcast to Di .. urth-Quarter and Full-Year 2011 Financial Results

[ Fri, Feb 17th 2012 ] - Market Wire

CHMP Recommends Approval of BYETTA for Use With Basal Insulin

[ Fri, Feb 17th 2012 ] - Market Wire

Digirad Corporation Reports Fourth Quarter and Full Year 2011 Financial Results

[ Fri, Feb 17th 2012 ] - Market Wire

Gilead Announces Data for Genotype 1 Null Respond .. r Hepatitis C Patients Enrolled in ELECTRON Study

[ Fri, Feb 17th 2012 ] - Market Wire

Angeion Corporation to Report First Quarter Fisca .. 2 Financial Results on Tuesday, February 28, 2012

[ Fri, Feb 17th 2012 ] - Market Wire

Improved Cord Blood Processing Research on BioLife Solutions CryoStor Published in TRANSFUSION

[ Fri, Feb 17th 2012 ] - Market Wire

Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer

Thu, February 16, 2012

[ Thu, Feb 16th 2012 ] - Market Wire

TheraSphere Providing Hope to Liver Cancer Patients in Turkey

[ Thu, Feb 16th 2012 ] - Market Wire

Horizon Receives Notice of Paragraph IV Certification Against Patents for DUEXIS(R)

[ Thu, Feb 16th 2012 ] - Market Wire

Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012

[ Thu, Feb 16th 2012 ] - Market Wire

Masimo annonce le programme Better Care -- Un pro .. ue l'h'pital pour une rduction des cots lis la tr

[ Thu, Feb 16th 2012 ] - Market Wire

Alexza Announces Proposed Public Offering of Common Stock and Warrants

[ Thu, Feb 16th 2012 ] - Market Wire

Kindred Healthcareas Year-End Conference Call Scheduled for February 24

[ Thu, Feb 16th 2012 ] - Market Wire

Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement

[ Thu, Feb 16th 2012 ] - Market Wire

Skilled Healthcare Group to Present at the RBC Global Healthcare Conference on February 29, 2012

[ Thu, Feb 16th 2012 ] - Market Wire

Skilled Healthcare Group to Present at the Citigr .. lobal Health Care Conference on February 28, 2012

[ Thu, Feb 16th 2012 ] - Market Wire

GeneLink Biosciences Completes Sale of GeneWize Life Sciences

[ Thu, Feb 16th 2012 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. n Their Investment in TranS1 Inc. of Class Action

DURECT to Participate in Upcoming Healthcare Conferences

_{//health-fitness.news-articles.net/content/2012/ .. ticipate-in-upcoming-healthcare-conferences.html}
^{Published in Health and Fitness on Thursday, February 23rd 2012 at 8:20 GMT by Market Wire}

DURECT to Participate in Upcoming Healthcare Conferences -- CUPERTINO, Calif., Feb. 23, 2012 /PRNewswire/ --

DURECT to Participate in Upcoming Healthcare Conferences

[ ]

[ Download image ]

CUPERTINO, Calif., Feb. 23, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: [ DRRX ]) announced today that management is scheduled to present at two upcoming healthcare conferences.

(Logo: [ http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ])

James E. Brown, President and CEO, will present at the RBC Capital Markets' Global Healthcare Conference on Wednesday, February 29 at 8:00 a.m. Eastern Time. The conference is being held at the New York Palace Hotel in New York City. A live audio webcast of the presentation will be available by accessing [ http://www.wsw.com/webcast/rbc141/drrx/ ].
James E. Brown, President and CEO, will also present at the Cowen and Company 32nd Annual Healthcare Conference on Wednesday, March 7 at 11:20 a.m. Eastern Time. The conference is being held at the Marriott Copley Place in Boston. A live audio webcast of the presentation will be available by accessing [ http://wsw.com/webcast/cowen6/drrx/ ].

A live audio webcast of these presentations will also be available by accessing DURECT's homepage at [ www.durect.com ] and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit [ www.durect.com ].

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, ELADUR™ and DURIN® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

SOURCE DURECT Corporation

[ Back to top ]

RELATED LINKS
[ http://www.durect.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire